Walleye Trading LLC Exelixis, Inc. Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$21.96 - $27.6 $1.23 Million - $1.54 Million	-55,900 Reduced 43.0%	74,100 $1.92 Million
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $406,800 - $474,600	-20,000 Reduced 13.33%	130,000 $2.92 Million
Q1 2024 May 15, 2024	BUY	$20.17 - $23.93 $1.21 Million - $1.44 Million	60,100 Added 66.85%	150,000 $3.56 Million
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $215,600 - $270,256	11,200 Added 14.23%	89,900 $2.16 Million
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $1.4 Million - $1.67 Million	73,600 Added 1443.14%	78,700 $1.72 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $1,817 - $2,048	100 Added 2.0%	5,100 $97,000
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $81,500 - $97,050	5,000 New	5,000 $97,000
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $327,712 - $465,443	-20,900 Reduced 80.69%	5,000 $78,000
Q2 2022 Aug 08, 2022	SELL	$17.44 - $23.16 $601,680 - $799,020	-34,500 Reduced 57.12%	25,900 $539,000
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $825,955 - $1.1 Million	48,500 Added 407.56%	60,400 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $285,120 - $393,840	-18,000 Reduced 60.2%	11,900 $218,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $370,010 - $479,878	22,700 Added 315.28%	29,900 $632,000
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $125,650 - $178,920	7,000 Added 3500.0%	7,200 $131,000
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $1.61 Million - $1.97 Million	-78,300 Reduced 99.75%	200 $5,000
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $1.06 Million - $1.43 Million	57,600 Added 275.6%	78,500 $1.58 Million
Q3 2020 Nov 16, 2020	BUY	$20.67 - $26.94 $432,003 - $563,046	20,900 New	20,900 $511,000
Q2 2020 Aug 14, 2020	SELL	$16.46 - $27.42 $1.41 Million - $2.34 Million	-85,500 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$14.46 - $21.8 $274,740 - $414,200	19,000 Added 28.57%	85,500 $1.47 Million
Q4 2019 Feb 14, 2020	BUY	$15.15 - $18.89 $796,890 - $993,614	52,600 Added 378.42%	66,500 $1.17 Million
Q3 2019 Nov 14, 2019	BUY	$17.68 - $22.65 $7,072 - $9,060	400 Added 2.96%	13,900 $246,000
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $117,366 - $153,450	-6,200 Reduced 31.47%	13,500 $288,000
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $1.57 Million - $1.98 Million	-79,900 Reduced 80.22%	19,700 $469,000
Q4 2018 Feb 14, 2019	BUY	$13.65 - $21.8 $1.26 Million - $2.01 Million	92,200 Added 1245.95%	99,600 $1.96 Million
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $265,029 - $374,080	-16,700 Reduced 69.29%	7,400 $131,000
Q2 2018 Aug 14, 2018	SELL	$18.56 - $22.45 $103,936 - $125,720	-5,600 Reduced 18.86%	24,100 $519,000
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $657,855 - $947,133	29,700 New	29,700 $658,000
Q3 2017 Nov 14, 2017	SELL	$23.35 - $29.24 $2,335 - $2,924	-100 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	100	100 $2,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account